about
Serious adverse events associated with yellow fever vaccineDetection of anti-yellow fever virus immunoglobulin m antibodies at 3-4 years following yellow fever vaccination.Experimental therapies for yellow fever17DD yellow fever vaccine: a double blind, randomized clinical trial of immunogenicity and safety on a dose-response study.Review of the risks and benefits of yellow fever vaccination including some new analyses.
P2860
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Persistence of yellow fever vaccine RNA in urine.
@en
type
label
Persistence of yellow fever vaccine RNA in urine.
@en
prefLabel
Persistence of yellow fever vaccine RNA in urine.
@en
P2093
P1433
P1476
Persistence of yellow fever vaccine RNA in urine
@en
P2093
Anna Vilella
Edward B Hayes
Isabel Vera
Miguel J Martínez
Montserrat Roldan
P304
P356
10.1016/J.VACCINE.2011.02.075
P407
P577
2011-03-06T00:00:00Z